compound tirzepatide ban update Troubling Findings in Study of GLP-1 Compounders FDA Ban on Compounded GLP-1

Some people experience spotting, which is light bleeding between periods, a few days after taking Plan B

The peptide is safe

The effect of intentional weight loss on fracture risk in persons with diabetes: results from the Look AHEAD randomized clinical trial

The pollsters reported that their findings indicate the obesity rate in the United States has decreased from a record high of nearly 40% in 2022 to 37% in 2025

The location of fat storage matters as much as the total amount

For patients already meeting indications for use of a GLP-1 drug based on metabolic factors, its potential role in lowering uveitis risk could be an added consideration when selecting antihyperglycemic therapy. 1 While these possibilities are positive advancements, a commentary on the study, also published yesterday in JAMA Ophthalmology , provides some potential limitations to keep in mind when interpreting conclusions